Medical Devices News and Research

RSS

Allergan third quarter diluted loss per share increases to $2.21

Allergan, Inc. today announced operating results for the quarter ended September 30, 2010. Allergan also announced that its Board of Directors has declared a third quarter dividend of $0.05 per share, payable on December 1, 2010 to stockholders of record on November 10, 2010.

1 Nov 2010

Vascular Pathways closes $14 million Series B equity financing round

Vascular Pathways Inc., a privately held medical device company with a breakthrough product for peripheral intravenous access, today announced that the company has closed a Series B preferred equity financing round of $14 million with premier venture capital firms active in medical technology.

1 Nov 2010

Wireless test solutions company LitePoint joins Continua Health Alliance

LitePoint Corporation, the leader in wireless test solutions, announced today it has joined Continua Health Alliance, along with other technology leaders.

1 Nov 2010

Dyadem opens second office to meet customer demand for enterprise risk management software

Dyadem today announced the opening of its second office in Europe; located in Starnberg, Germany, on the outskirts of Munich. Dyadem, the leader in Operational and Quality Risk Management, has expanded in response to a surge in customer demand in the European Union for its enterprise risk management software and services amid heightened scrutiny of safety and quality standards for companies in the oil & gas, chemical, medical device and pharmaceutical industries.

1 Nov 2010

2010 Mid-Atlantic Bio a great kick-off for hosting 2011 BIO International Convention

The 2010 Mid-Atlantic Bio today completed another successful conference hosting 728 registrants from 22 states and 4 countries, with more than 400 companies and 50 qualified investors participating. Dedicated to promoting the biotechnology industry in the Mid-Atlantic region, the conference is hosted collectively by the region's most influential bioscience and investor associations, the Mid-Atlantic Venture Association (MAVA), the Tech Council of Maryland/MdBio (MdBio) and the Virginia Biotechnology Association (VaBIO).

30 Oct 2010

Drug and device makers face new taxes, fees

A Fox Business report shows the health overhaul is cutting deeper into drug and device makers' profits than many expected. Research & development programs are already being drastically scaled back.

30 Oct 2010

Coherex achieves two milestones in structural heart disease field

In honor of World Stroke Day (October 29, 2010), Coherex Medical, Inc. today announced it has achieved two milestones that further strengthen its position as an emerging medical device company in the field of structural heart disease.

29 Oct 2010

Boston Scientific's Neurovascular business to be acquired by Stryker

Boston Scientific Corporation today announced the execution of a definitive agreement under which Stryker Corporation will acquire Boston Scientific's Neurovascular business. The purchase price is $1.5 billion, payable in cash, of which $1.4 billion is payable at closing and $100 million will be payable following the closing and upon the occurrence of the commercialization of the next-generation Target™ Detachable Coils and the transfer or separation of certain manufacturing facilities, which is anticipated to occur over a period of approximately 24 months.

From Stryker 29 Oct 2010

IntriCon third quarter net sales increases 14% to $14.7 million

IntriCon Corporation a designer, developer, manufacturer and distributor of body-worn medical devices, today announced financial results for its third quarter ended September 30, 2010.

29 Oct 2010

Today's Op-Eds: Medicare rip-offs; Courts and the individual mandate; Accountable care

Instead of getting hung up on labels adopted in the heat of political battle, they should focus instead on Supreme Court precedents that found that taxes designed to influence behavior, like taxes to deter the sale of particularly dangerous firearms, were constitutional, provided they raised revenue in the process.

29 Oct 2010

Encision second quarter net sales decrease 11% to $2.87 million

Encision Inc., a medical device company owning patented surgical technology that is emerging as a standard of care in minimally-invasive surgery, reported its financial results for its second fiscal quarter ended September 30, 2010.

28 Oct 2010

RExpert to discuss latest advancements in musculoskeletal bioengineering at NCKU International Symposium

The 4th International Symposium and Workshop on Virtual Interactive Musculoskeletal System, organized by National Cheng Kung University, Taiwanese Society of Biomechanics and Taiwanese Society of Biomechanics in Sports, is held on October 28th and 29th in International Conference Hall, Kuang-Fu Campus, National Cheng Kung University (NCKU), Tainan, Taiwan,

28 Oct 2010

CECOLFES fertility treatment results demonstrate effectiveness of INVOcell cycle process

INVO Bioscience, Inc., a medical device company focused on treatment options for patients diagnosed with infertility, announced today that Dr. Elkin Lucena of the Columbian Fertility and Sterility Center (CECOLFES LTDA) in Bogota, Colombia presented the results of the Center's first 95 fertility treatment cycles utilizing INVO Bioscience's INVOcell for couples with fertility issues at the 66th Annual Meeting of the American Society of Reproductive Medicine (ASRM) in Denver.

28 Oct 2010

Annals of Urology to publish NAFC research on overactive bladder symptoms

Research by the National Association For Continence (NAFC) about the frustration endured by middle-aged women, who have overactive bladder (OAB) symptoms, will be published in the inaugural issue of Annals of Urology from San Lucas Medical.

28 Oct 2010

Endologix announces definitive agreement to acquire Nellix

Endologix, Inc., developer of minimally invasive treatments for aortic disorders, announced today that it has signed a definitive agreement to acquire Nellix, Inc, a privately-held medical device company that has developed a revolutionary endograft for the treatment of Abdominal Aortic Aneurysms (AAAs).

28 Oct 2010

Endologix 2010 third quarter total revenue increases 30% to $17.9 million

Endologix, Inc. developer of minimally invasive treatments for aortic disorders, today announced financial results for the three and nine months ended September 30, 2010.

28 Oct 2010

Baxa announces 2011 dates for courses at STAR Center training facility

Baxa Corporation, a leading provider of medical devices and systems that automate pharmacy operations, today announced the 2011 dates for its STAR (Skills Training, Academics and Resources) Center. Located at the Baxa global headquarters in Englewood CO, the STAR Center furthers best practice in health-system pharmacy operations. The ACPE-accredited 2011 curriculum offers participants hands-on training in a state-of-the-art cleanroom and pharmacy training facility.

27 Oct 2010

CJPS Medical releases VitalPoint device to improve healthcare

CJPS Medical Systems releases VitalPoint this week, a medical device capable of measuring patients' vital signs from home, while allowing direct communication with their caregiver, and generating and saving HIPAA-compliant electronic medical records.

27 Oct 2010

CHI releases new white paper on 510(k) review process

California Healthcare Institute today announced the release of a new white paper titled "Upcoming Changes to the 510(k) Process: New Approval Pathways and the Impact on Medical Device Development and Innovation." CHI is a non-profit public policy research and advocacy organization, representing leading California academic institutions, biotechnology, medical device, diagnostics and pharmaceutical firms.

27 Oct 2010

PPD and VirtualScopics partner to provide medical imaging services

PPD, Inc. and VirtualScopics, Inc. today announced a strategic alliance to deliver a comprehensive set of clinical and medical imaging services that will enable biopharmaceutical companies to make faster, more confident decisions on the development of their oncology compounds, creating time and cost efficiencies.

26 Oct 2010